Spatial Transcriptomics Meets Histochemistry: Insights from Glioblastoma as a Model System
Syuri Tomioka1, Riko Kitazawa1,2, Ryuma Haraguchi1
1Department of Molecular Pathology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
Acta Histochemica Et Cytochemica
|March 11, 2026
Summary
High-resolution spatial transcriptomics reveals gene expression in glioblastoma (GBM) tissue. Integrating spatial transcriptomics with histochemistry enhances neuropathological interpretation but does not replace microscopy.
Area of Science:
- Neuropathology
- Molecular Biology
- Genomics
Background:
- High-resolution spatial transcriptomics links gene expression to tissue architecture.
- Morphological context is crucial for neuropathology and disease interpretation.
- Glioblastoma multiforme (GBM) is a highly heterogeneous cancer model.
Purpose of the Study:
- Evaluate strengths and limitations of spatial transcriptomics in neuropathology.
- Compare spatial transcriptomics with classical histochemistry and cytochemistry.
- Demonstrate integration of spatial transcriptomics with histopathology for GBM research.
Main Methods:
- Review of high-resolution spatial transcriptomic platforms.
- Analysis of human GBM tissue using spatial transcriptomics.
- Comparison with histochemical and immunohistochemical methods.
Main Results:
- Spatial transcriptomics captures GBM gene expression patterns and maps pathological features like necrosis and tumor vasculature.
- Integration with histopathology generates hypotheses on immune suppression and proliferation.
- Spatial transcriptomics complements but does not replace direct microscopic evaluation.
Conclusions:
- Spatial transcriptomics bridges morphology and molecular biology in histopathological research.
- Limitations include morphological fidelity and lack of subcellular resolution.
- Effective integration requires rigorous histochemical knowledge for accurate interpretation and translational relevance.
